460 related articles for article (PubMed ID: 32164782)
1. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review.
Shan F; MacVicar S; Allegaert K; Offringa M; Jansson LM; Simpson S; Moulsdale W; Kelly LE
Trials; 2020 Mar; 21(1):262. PubMed ID: 32164782
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
3. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Wachman EM; Schiff DM; Silverstein M
JAMA; 2018 Apr; 319(13):1362-1374. PubMed ID: 29614184
[TBL] [Abstract][Full Text] [Related]
4. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Abstinence Syndrome.
Jansson LM; Patrick SW
Pediatr Clin North Am; 2019 Apr; 66(2):353-367. PubMed ID: 30819342
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
MacMillan KDL
Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
[TBL] [Abstract][Full Text] [Related]
7. [Neonatal abstinence syndrome after maternal use of tramadol].
de Wit D; Koomen-Botman I
Ned Tijdschr Geneeskd; 2013; 157(9):A5610. PubMed ID: 23446156
[TBL] [Abstract][Full Text] [Related]
8. Delivery timing for the opioid-exposed infant.
Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R
Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700
[TBL] [Abstract][Full Text] [Related]
9. Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome.
MacVicar S; Kelly LE
Birth; 2019 Sep; 46(3):428-438. PubMed ID: 30938466
[TBL] [Abstract][Full Text] [Related]
10. Maternal hair cortisol levels as a novel predictor of neonatal abstinence syndrome severity: A pilot feasibility study.
Wachman EM; Hunter RG; Shrestha H; Lapp HE; Meyer J; Alvarez CD; Tronick E
Dev Psychobiol; 2020 Jan; 62(1):116-122. PubMed ID: 31342518
[TBL] [Abstract][Full Text] [Related]
11. Impact of
Bailey BA; Shah DS; Boynewicz KL; Justice NA; Wood DL
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9383-9390. PubMed ID: 35109759
[TBL] [Abstract][Full Text] [Related]
12. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
[TBL] [Abstract][Full Text] [Related]
13. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses.
Shuman CJ; Wilson R; VanAntwerp K; Morgan M; Weber A
BMC Pediatr; 2021 Nov; 21(1):489. PubMed ID: 34736443
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic management of neonatal abstinence syndrome in a community hospital.
Napolitano A; Theophilopoulos D; Seng SK; Calhoun DA
Clin Obstet Gynecol; 2013 Mar; 56(1):193-201. PubMed ID: 23314713
[TBL] [Abstract][Full Text] [Related]
16. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
Mills-Huffnagle S; Nyland JE
BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
[TBL] [Abstract][Full Text] [Related]
18. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
19. Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.
Wiles JR; Isemann B; Ward LP; Vinks AA; Akinbi H
J Pediatr; 2014 Sep; 165(3):440-6. PubMed ID: 24948346
[No Abstract] [Full Text] [Related]
20. A Core Outcome Set for Neonatal Opioid Withdrawal Syndrome.
Kelly LE; Shan F; MacVicar S; Czaplinksi E; Moulsdale W; Simpson S; Allegaert K; Jansson LM; Offringa M
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32493710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
